SCHEMBL25394185

SCHEMBL25394185

CCCCOC(=O)N1C2CC(F)CC1C2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ LMNA P02545 3/20 0.43
▸ POLB P06746 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.40
▸ ATM Q13315 1/20 0.38
▸ GBA2 Q9HCG7 1/20 0.37
▸ TSHR P16473 4/20 0.36
▸ HPGD P15428 1/20 0.36
▸ BCHE P06276 1/20 0.35
▸ ESR1 P03372 4/20 0.34
▸ HCAR2 Q8TDS4 1/20 0.34
▸ NAAA Q02083 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ CYP1A2 P05177 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ NR1H2 P55055 1/20 0.32
▸ RNASEL Q05823 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22325282 0.92 SMN1; SMN2 (0.40) SMN1; SMN2LMNAPOLBALDH1A1ATM
SCHEMBL25394536 0.85 SMN1; SMN2 (0.44) SMN1; SMN2LMNAPOLBALDH1A1ATM
SCHEMBL26923244 0.84 SMN1; SMN2 (0.43) SMN1; SMN2LMNAPOLBALDH1A1ATM
SCHEMBL26923262 0.81 LMNA (0.38) SMN1; SMN2LMNAPOLBALDH1A1ATM
SCHEMBL31692676 0.81 LMNA (0.43) SMN1; SMN2LMNAPOLBALDH1A1ATM
SCHEMBL26922978 0.80 SMN1; SMN2 (0.43) SMN1; SMN2LMNAPOLBALDH1A1ATM
SCHEMBL26923200 0.78 LMNA (0.38) SMN1; SMN2LMNAPOLBALDH1A1ATM
SCHEMBL8259202 0.77 LMNA (0.43) SMN1; SMN2LMNAPOLBALDH1A1ATM
SCHEMBL12199159 0.77 LMNA (0.45) SMN1; SMN2LMNAPOLBALDH1A1ATM
SCHEMBL30532513 0.76 LMNA (0.42) SMN1; SMN2LMNAPOLBALDH1A1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023168298-A2 COMPOUNDS, COMPOSITIONS, AND METHODS DENALI THERAPEUTICS INC. (US) 2023-09-07 — — WO disclosed
Send feedback